Although overexpression of IL20RA in breast tumor cells decreased the percentage of CD8+ T-cells in the tumor microenvironment, NPs-Stattic-IL20RA plus IgG did not increase the percentage of these cells compared with the IgG control. The gene discussed is CD8A; the disease is breast neoplasm.